Twist Bioscience Corporation Summary
Twist Bioscience Corporation is a synthetic biology company that manufactures and sells synthetic DNA-based products. Their DNA synthesis platform allows for the manufacturing of synthetic DNA through writing DNA on a silicon chip. They offer a range of synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery, and DNA as a digital data storage medium. The company has partnerships with various organizations for the development of advanced sequencing tools, as well as a research collaboration for the discovery of therapeutic antibodies.
Symbol
TWST
General Information
Company Name
Twist Bioscience Corporation
Sector
Healthcare
Industry
Diagnostics & Research
Stock Multiplier
5.34X
P/E Ratio
-14.89X
Assets
Cash and Cash Equivalents
210.44 Million 
Total Current Assets
338.44 Million
Total Non-current Assets
257.17 Million
Inventories
20.86 Million
Net Accounts Receivable
49.95 Million 
Property, Plant, and Equipment
184.64 Million
Total Assets
595.62 Million
Goodwill
85.81 Million
Net Property, Plant, and Equipment
97.14 Million
Liabilities
Total Liabilities
155.51 Million 
Total Current Liabilities
74.98 Million
Total Non-current Liabilities
80.53 Million
Long-term Debt
N/A
Short-term Debt
N/A
Accounts Payable
8.06 Million
Share Information
Shares Issued
59.86 Million
Basic Shares Outstanding
59.86 Million
Shares Authorized
200 Million
Shareholders' Equity
Retained Earnings
-1.31 Billion
Total Shareholders' Equity
440.11 Million
Income
Gross Revenue
92.79 Million
Net Income
-39.33 Million
Basic Earnings per Share
-0.66
Diluted Earnings per Share
-0.66
Operating Income
-41.56 Million
Expenses
Selling, General, and Administrative
63.67 Million
Research and Development
23.92 Million
Operating Expenses
134.35 Million
Stock Info
Current Price
$27.89
Market Cap
$1.67B
Monthly Low
$24.16
Yearly Low
$24.16
Monthly High
$27.95
Yearly High
$54.07
Monthly Avg
$26.40
Yearly Avg
$39.2
Monthly Volatility
Low
Yearly Volatility
High
Recent Twist Bioscience Corporation News
09/06/2025
Hawk Ridge Capital Management LP Trims Stock Holdings in Twist Bioscience Corporation $TWST
09/02/2025
Ieq Capital LLC Purchases 24,817 Shares of Twist Bioscience Corporation $TWST
08/27/2025
Wellington Management Group LLP Lowers Holdings in Twist Bioscience Corporation $TWST
08/08/2025
What is William Blair's Forecast for TWST FY2025 Earnings?
08/05/2025
Twist Bioscience (NASDAQ:TWST) Posts Earnings Results, Beats Expectations By $0.07 EPS
08/04/2025
Twist Bioscience Corporation 2025 Q3 - Results - Earnings Call Presentation
08/04/2025
Twist Bioscience Corporation (TWST) Q3 2025 Earnings Call Transcript
08/04/2025
Twist Bioscience (TWST) Q3 Profit Surges
08/04/2025
Twist Bioscience Corporation (NASDAQ:TWST) Shares Acquired by IQ EQ FUND MANAGEMENT IRELAND Ltd
08/04/2025
Universal Beteiligungs und Servicegesellschaft mbH Purchases New Shares in Twist Bioscience Corporation (NASDAQ:TWST)
Twist Bioscience Corporation Stock vs Fundamentals
Recommendation
Hold
Twist Bioscience Corporation Stock Forecast
category
sentiment
volatility
growth
forecast
Diagnostics & Research
Industry Forecast
Data as of: 09/19/2025
Outperformers
CareDx, Inc
+9%
Invitae Corporation
+7%
Lantheus Holdings, Inc.
+6%
Underperformers
Natera, Inc.
-2%
Charles River Laboratories International, Inc.
-2%
IQVIA Holdings Inc.
-2%